Key Highlights
- Primary Products Liability coverage tailored for life sciences companies.
- Provides up to $10 million in capacity for qualified customers.
- Coverage includes PCO, E&O, PSL, and Clinical Trials.
- Flexible options like worldwide territory and extended reporting periods.
- Supported by dedicated Life Sciences underwriters and risk engineering specialists.
Source: PR Newswire
Notable Quotes
- “Our new Primary Products Liability offering is an essential, customizable coverage that can help support life sciences companies’ efforts to innovate and enhance quality of life for people.” — Alex Wells, Head of U.S. Middle Market at Zurich North America
- “This offering is backed by the advanced knowledge and experience of our dedicated Life Sciences underwriting team as well as risk engineering and claims specialists, allowing brokers who work with us to be confident in our ability to appropriately structure whole-account solutions and service these clients’ needs.” — Linda Schultz, Head of Life Sciences at Zurich North America
SoHC's Take
Zurich North America’s introduction of Primary Products Liability coverage marks a significant development for life sciences companies, particularly those with revenues up to $1 billion. This new offering provides comprehensive and customizable coverage that addresses the unique risks associated with pharmaceuticals, medtech, and other life sciences sectors. The inclusion of key coverage components like Products-completed operations liability, Errors and Omissions, Professional Services Liability, and Clinical trials underscores Zurich’s commitment to supporting innovation in human health. By leveraging Zurich’s financial strength and global reach, life sciences companies can confidently pursue their mission of advancing healthcare solutions worldwide.
